OpenURL Connection Search

Select item for more details and to access through your institution.

PD-L1 PET/CT imaging with radiolabeled durvalumab in patients with advanced stage non-small cell lung cancer.
Published in:
Journal of Nuclear Medicine, 2021, v. 62, n. 12, p. 1, doi. 10.2967/jnumed.121.262473
By:
- Smit, Jasper;
- Borm, Frank J;
- Niemeijer, Anna-Larissa N;
- Huisman, Marc C.;
- Hoekstra, Otto S.;
- Boellaard, Ronald;
- Oprea – Lager, Daniela E.;
- Vugts, Danielle J.;
- van Dongen, Guus AMS;
- de Wit-van der Veen, Berlinda J.;
- Thunnissen, Erik;
- Smit, Egbert F.;
- de Langen, Adrianus J
Publication type:
Article
First-in-human study of 89Zr-pembrolizumab PET/CT in patients with advanced stage non-smallcell lung cancer.
Published in:
Journal of Nuclear Medicine, 2021, v. 62, n. 12, p. 1, doi. 10.2967/jnumed.121.261926
By:
- Niemeijer, Anna-Larissa N.;
- Oprea-Lager, Daniela E.;
- Huisman, Marc C.;
- Hoekstra, Otto S.;
- Boellaard, Ronald;
- de Wit-van der Veen, Berlinda J.;
- Bahce, Idris;
- Vugts, Daniëlle J.;
- van Dongen, Guus AMS;
- Thunnissen, Erik;
- Smit, Egbert F.;
- de Langen, Adrianus J.
Publication type:
Article
First-in-human study of 89Zr-pembrolizumab PET/CT in patients with advanced stage non-smallcell lung cancer.
Published in:
Journal of Nuclear Medicine, 2021, v. 62, n. 12, p. 1, doi. 10.2967/jnumed.121.261926
By:
- Niemeijer, Anna-Larissa N.;
- Oprea-Lager, Daniela E.;
- Huisman, Marc C.;
- Hoekstra, Otto S.;
- Boellaard, Ronald;
- de Wit-van der Veen, Berlinda J.;
- Bahce, Idris;
- Vugts, Daniëlle J.;
- van Dongen, Guus A. M. S.;
- Thunnissen, Erik;
- Smit, Egbert F.;
- de Langen, Adrianus J.
Publication type:
Article
PD-L1 PET/CT imaging with radiolabeled durvalumab in patients with advanced stage non-small cell lung cancer.
Published in:
Journal of Nuclear Medicine, 2021, v. 62, n. 11, p. 1, doi. 10.2967/jnumed.121.262473
By:
- Smit, Jasper;
- Borm, Frank J.;
- Niemeijer, Anna-Larissa N.;
- Huisman, Marc C.;
- Hoekstra, Otto S.;
- Boellaard, Ronald;
- Oprea – Lager, Daniela E.;
- Vugts, Danielle J.;
- van Dongen, Guus A. M. S.;
- de Wit- van der Veen, Berlinda J.;
- Thunnissen, Erik;
- Smit, Egbert F.;
- de Langen, Adrianus J.
Publication type:
Article
First-in-human study of 89Zr-pembrolizumab PET/CT in patients with advanced stage non-small- cell lung cancer . .
Published in:
Journal of Nuclear Medicine, 2021, v. 62, n. 11, p. 1, doi. 10.2967/jnumed.121.261926
By:
- Niemeijer, Anna-Larissa N.;
- Oprea-Lager, Daniela E.;
- Huisman, Marc C.;
- Hoekstra, Otto S;
- Boellaard, Ronald;
- de Wit-van der Veen, Berlinda J.;
- Bahce, Idris.;
- Vugts, Daniëlle J.;
- van Dongen, Guus AMS;
- Thunnissen, Erik;
- Smit, Egbert F.;
- de Langen, Adrianus J.
Publication type:
Article
First-in-human study of 89Zr-pembrolizumab PET/CT in patients with advanced stage non-smallcell lung cancer.
Published in:
Journal of Nuclear Medicine, 2021, v. 62, n. 11, p. 1, doi. 10.2967/jnumed.121.261926
By:
- Niemeijer, Anna-Larissa N.;
- Oprea-Lager, Daniela E.;
- Huisman, Marc C.;
- Hoekstra, Otto S.;
- Boellaard, Ronald;
- de Wit-van der Veen, Berlinda J.;
- Bahce, Idris;
- Vugts, Daniëlle J.;
- van Dongen, Guus A. M. S.;
- Thunnissen, Erik;
- Smit, Egbert F.;
- de Langen, Adrianus J.
Publication type:
Article
PD-L1 PET/CT imaging with radiolabeled durvalumab in patients with advanced stage non-small cell lung cancer.
Published in:
Journal of Nuclear Medicine, 2021, v. 62, n. 10, p. 1, doi. 10.2967/jnumed.121.262473
By:
- Smit, Jasper;
- Borm, Frank J.;
- Niemeijer, Anna-Larissa N.;
- Huisman, Marc C.;
- Hoekstra, Otto S.;
- Boellaard, Ronald;
- Oprea–Lager, Daniela E.;
- Vugts, Danielle J.;
- van Dongen, Guus AMS;
- de Wit-van der Veen, Berlinda J.;
- Thunnissen, Erik;
- Smit, Egbert F.;
- de Langen, Adrianus J.
Publication type:
Article
First-in-human study of 89Zr-pembrolizumab PET/CT in patients with advanced stage non-small-cell lung cancer.
Published in:
Journal of Nuclear Medicine, 2021, v. 62, n. 10, p. 1, doi. 10.2967/jnumed.121.261926
By:
- Niemeijer, Anna-Larissa N.;
- Oprea-Lager, Daniela E.;
- Huisman, Marc C.;
- Hoekstra, Otto S.;
- Boellaard, Ronald;
- de Wit-van der Veen, Berlinda J.;
- Bahce, Idris;
- Vugts, Daniëlle J.;
- van Dongen, Guus AMS;
- Thunnissen, Erik;
- Smit, Egbert F.;
- de Langen, Adrianus J.
Publication type:
Article
PD-L1 PET/CT imaging with radiolabeled durvalumab in patients with advanced stage non-small cell lung cancer.
Published in:
Journal of Nuclear Medicine, 2021, v. 62, n. 8, p. 1, doi. 10.2967/jnumed.121.262473
By:
- Smit, Jasper;
- Borm, Frank J.;
- Niemeijer, Anna-Larissa N.;
- Huisman, Marc C.;
- Hoekstra, Otto S.;
- Boellaard, Ronald;
- Oprea-Lager, Daniela E.;
- Vugts, Danielle J.;
- van Dongen, Guus A. M. S.;
- de Wit-van der Veen, Berlinda J.;
- Thunnissen, Erik;
- Smit, Egbert F.;
- de Langen, Adrianus J.
Publication type:
Article
First-in-human study of 89Zr-pembrolizumab PET/CT in patients with advanced stage non-small-cell lung cancer.
Published in:
Journal of Nuclear Medicine, 2021, v. 62, n. 8, p. 1, doi. 10.2967/jnumed.121.261926
By:
- Niemeijer, Anna-Larissa N.;
- Oprea-Lager, Daniela E.;
- Huisman, Marc C.;
- Hoekstra, Otto S.;
- Boellaard, Ronald;
- de Wit-van der Veen, Berlinda J.;
- Bahce, Idris;
- Vugts, Daniëlle J.;
- van Dongen, Guus A. M. S.;
- Thunnissen, Erik;
- Smit, Egbert F.;
- de Langen, Adrianus J.
Publication type:
Article
First-in-human study of 89Zr-pembrolizumab PET/CT in patients with advanced stage non-small-cell lung cancer.
Published in:
Journal of Nuclear Medicine, 2021, v. 62, n. 7, p. 1, doi. 10.2967/jnumed.121.261926
By:
- Niemeijer, Anna-Larissa N.;
- Oprea-Lager, Daniela E.;
- Huisman, Marc C.;
- Hoekstra, Otto S.;
- Boellaard, Ronald;
- de Wit-van der Veen, Berlinda J.;
- Bahce, Idris;
- Vugts, Daniëlle J.;
- van Dongen, Guus A. M. S.;
- Thunnissen, Erik;
- Smit, Egbert F.;
- de Langen, Adrianus J.
Publication type:
Article
Quantification of PD-L1 expression with [18F]BMS-986192 PET/CT in patients with advanced stage non-small-cell lung cancer.
Published in:
Journal of Nuclear Medicine, 2020, v. 61, n. 12, p. 1, doi. 10.2967/jnumed.119.240895
By:
- Huisman, Marc C.;
- Niemeijer, Anna-Larissa N.;
- Windhorst, Albert D.;
- Schuit, Robert C.;
- Leung, David;
- Hayes, Wendy;
- Poot, Alex;
- Bahce, Idris;
- Radonic, Teodora;
- Oprea-Lager, Daniela E.;
- Hoekstra, Otto S.;
- Thunnissen, Erik;
- Hendrikse, Harry;
- Smit, Egbert F.;
- de Langen, Adrianus J.;
- Boellaard, Ronald
Publication type:
Article
Quantification of PD-L1 expression with [18F]BMS-986192 PET/CT in patients with advanced stage non-small-cell lung cancer.
Published in:
Journal of Nuclear Medicine, 2020, v. 61, n. 11, p. 1, doi. 10.2967/jnumed.119.240895
By:
- Huisman, Marc C.;
- Niemeijer, Anna-Larissa N.;
- Windhorst, Albert D.;
- Schuit, Robert C.;
- Leung, David;
- Hayes, Wendy;
- Poot, Alex;
- Bahce, Idris;
- Radonic, Teodora;
- Oprea-Lager, Daniela E.;
- Hoekstra, Otto S.;
- Thunnissen, Erik;
- Hendrikse, N. Harry;
- Smit, Egbert F.;
- de Langen, Adrianus J.;
- Boellaard, Ronald
Publication type:
Article
Quantification of PD‐L1 expression with [ 18F]BMS‐986192 PET/CT in patients with advanced stage non‐small‐cell lung cancer.
Published in:
Journal of Nuclear Medicine, 2020, v. 61, n. 10, p. 1, doi. 10.2967/jnumed.119.240895
By:
- Huisman, Marc C;
- Niemeijer, Anna‐Larissa N;
- Windhorst, Albert D;
- Schuit, Robert C;
- Leung, David;
- Hayes, Wendy;
- Poot, Alex;
- Bahce, Idris;
- Radonic, Teodora;
- Oprea‐Lager, Daniela E;
- Hoekstra, Otto S;
- Thunnissen, Erik;
- Harry Hendrikse, N.;
- Smit, Egbert F;
- de Langen, Adrianus J;
- Boellaard, Ronald
Publication type:
Article
Quantification of PD‐L1 expression with [18F]BMS‐986192 PET/CT in patients with advanced stage non‐small‐cell lung cancer.
Published in:
Journal of Nuclear Medicine, 2020, v. 61, n. 9, p. 1, doi. 10.2967/jnumed.119.240895
By:
- Huisman, Marc C.;
- Niemeijer, Anna-Larissa N.;
- Windhorst, Albert D.;
- Schuit, Robert C.;
- Leung, David;
- Hayes, Wendy;
- Poot, Alex;
- Bahce, Idris;
- Radonic, Teodora;
- Oprea-Lager, Daniela E.;
- Hoekstra, Otto S.;
- Thunnissen, Erik;
- Hendrikse, N. Harry;
- Smit, Egbert F.;
- de Langen, Adrianus J.;
- Boellaard, Ronald
Publication type:
Article
Quantification of PD‐L1 expression with [18F]BMS‐986192 PET/CT in patients with advanced stage non‐small‐cell lung cancer.
Published in:
Journal of Nuclear Medicine, 2020, v. 61, n. 8, p. 1, doi. 10.2967/jnumed.119.240895
By:
- Huisman, Marc C.;
- Niemeijer, Anna‐Larissa N.;
- Windhorst, Albert D.;
- Schuit, Robert C.;
- Leung, David;
- Hayes, Wendy;
- Poot, Alex;
- Bahce, Idris;
- Radonic, Teodora;
- Oprea‐Lager, Daniela E.;
- Hoekstra, Otto S.;
- Thunnissen, Erik;
- Hendrikse, N. Harry;
- Smit, Egbert F.;
- de Langen, Adrianus J.;
- Boellaard, Ronald
Publication type:
Article
Quantification of PD-L1 expression with [18F]BMS-986192 PET/CT in patients with advanced stage non-small-cell lung cancer.
Published in:
Journal of Nuclear Medicine, 2020, v. 61, n. 7, p. 1, doi. 10.2967/jnumed.119.240895
By:
- Huisman, Marc C.;
- Niemeijer, Anna-Larissa N.;
- Windhorst, Albert D.;
- Schuit, Robert C.;
- Leung, David;
- Hayes, Wendy;
- Poot, Alex;
- Bahce, Idris;
- Radonic, Teodora;
- Oprea-Lager, Daniela E.;
- Hoekstra, Otto S.;
- Thunnissen, Erik;
- Hendrikse, N. Harry;
- Smit, Egbert F.;
- de Langen, Adrianus J.;
- Boellaard, Ronald
Publication type:
Article
Quantification of PD‐L1 expression with [ 18F]BMS‐986192 PET/CT in patients with advanced stage non‐small‐cell lung cancer.
Published in:
Journal of Nuclear Medicine, 2020, v. 61, n. 6, p. 1, doi. 10.2967/jnumed.119.240895
By:
- Huisman, Marc C.;
- Niemeijer, Anna‐Larissa N;
- Windhorst, Albert D.;
- Schuit, Robert C.;
- Leung, David;
- Hayes, Wendy;
- Poot, Alex;
- Bahce, Idris;
- Radonic, Teodora;
- Oprea‐Lager, Daniela E.;
- Hoekstra, Otto S.;
- Thunnissen, Erik;
- Harry Hendrikse, N.;
- Smit, Egbert F.;
- de Langen, Adrianus J.;
- Boellaard, Ronald
Publication type:
Article
Quantification of PD-L1 expression with [18F]BMS-986192 PET/CT in patients with advanced stage non-small-cell lung cancer.
Published in:
Journal of Nuclear Medicine, 2020, v. 61, n. 5, p. 1, doi. 10.2967/jnumed.119.240895
By:
- Huisman, Marc C.;
- Niemeijer, Anna-Larissa N.;
- Windhorst, Albert D.;
- Schuit, Robert C.;
- Leung, David;
- Hayes, Wendy;
- Poot, Alex;
- Bahce, Idris;
- Radonic, Teodora;
- EOprea-Lager, Daniela;
- Hoekstra, Otto S.;
- Thunnissen, Erik;
- Hendrikse, N. Harry;
- Smit, Egbert F.;
- de Langen, Adrianus J.;
- Boellaard, Ronald
Publication type:
Article
Quantification of PD-L1 expression with [18F]BMS-986192 PET/CT in patients with advanced stage non-small-cell lung cancer.
Published in:
Journal of Nuclear Medicine, 2020, v. 61, n. 4, p. 1, doi. 10.2967/jnumed.119.240895
By:
- Huisman, Marc C.;
- Niemeijer, Anna-Larissa N.;
- Windhorst, Albert D.;
- Schuit, Robert C.;
- Leung, David;
- Hayes, Wendy;
- Poot, Alex;
- Bahce, Idris;
- Radonic, Teodora;
- Oprea-Lager, Daniela E.;
- Hoekstra, Otto S.;
- Thunnissen, Erik;
- Hendrikse, N. Harry;
- Smit, Egbert F.;
- de Langen, Adrianus J.;
- Boellaard, Ronald
Publication type:
Article
Quantification of PD‐L1 expression with [18F]BMS‐986192 PET/CT in patients with advanced stage non‐small‐cell lung cancer.
Published in:
Journal of Nuclear Medicine, 2020, v. 61, n. 3, p. 1, doi. 10.2967/jnumed.119.240895
By:
- Huisman, Marc C.;
- Niemeijer, Anna‐Larissa N.;
- Windhorst, Albert D.;
- Schuit, Robert C.;
- Leung, David;
- Hayes, Wendy;
- Poot, Alex;
- Bahce, Idris;
- Radonic, Teodora;
- Oprea‐Lager, Daniela E.;
- Hoekstra, Otto S.;
- Thunnissen, Erik;
- Hendrikse, N. Harry;
- Smit, Egbert F.;
- de Langen, Adrianus J.;
- Boellaard, Ronald
Publication type:
Article

Found: 21

PD-L1 PET/CT imaging with radiolabeled durvalumab in patients with advanced stage non-small cell lung cancer.

First-in-human study of <sup>89</sup>Zr-pembrolizumab PET/CT in patients with advanced stage non-smallcell lung cancer.

First-in-human study of <sup>89</sup>Zr-pembrolizumab PET/CT in patients with advanced stage non-smallcell lung cancer.

PD-L1 PET/CT imaging with radiolabeled durvalumab in patients with advanced stage non-small cell lung cancer.

First-in-human study of 89Zr-pembrolizumab PET/CT in patients with advanced stage non-small- cell lung cancer . .

First-in-human study of 89Zr-pembrolizumab PET/CT in patients with advanced stage non-smallcell lung cancer.

PD-L1 PET/CT imaging with radiolabeled durvalumab in patients with advanced stage non-small cell lung cancer.

First-in-human study of<sup> 89</sup>Zr-pembrolizumab PET/CT in patients with advanced stage non-small-cell lung cancer.

PD-L1 PET/CT imaging with radiolabeled durvalumab in patients with advanced stage non-small cell lung cancer.

First-in-human study of <sup>89</sup>Zr-pembrolizumab PET/CT in patients with advanced stage non-small-cell lung cancer.

First-in-human study of <sup>89</sup>Zr-pembrolizumab PET/CT in patients with advanced stage non-small-cell lung cancer.

Quantification of PD-L1 expression with [<sup>18</sup>F]BMS-986192 PET/CT in patients with advanced stage non-small-cell lung cancer.

Quantification of PD-L1 expression with [18F]BMS-986192 PET/CT in patients with advanced stage non-small-cell lung cancer.

Quantification of PD‐L1 expression with [ <sup>18</sup>F]BMS‐986192 PET/CT in patients with advanced stage non‐small‐cell lung cancer.

Quantification of PD‐L1 expression with [<sup>18</sup>F]BMS‐986192 PET/CT in patients with advanced stage non‐small‐cell lung cancer.

Quantification of PD‐L1 expression with [<sup>18</sup>F]BMS‐986192 PET/CT in patients with advanced stage non‐small‐cell lung cancer.

Quantification of PD-L1 expression with [<sup>18</sup>F]BMS-986192 PET/CT in patients with advanced stage non-small-cell lung cancer.

Quantification of PD‐L1 expression with [ 18F]BMS‐986192 PET/CT in patients with advanced stage non‐small‐cell lung cancer.

Quantification of PD-L1 expression with [18F]BMS-986192 PET/CT in patients with advanced stage non-small-cell lung cancer.

Quantification of PD-L1 expression with [<sup>18</sup>F]BMS-986192 PET/CT in patients with advanced stage non-small-cell lung cancer.

Quantification of PD‐L1 expression with [<sup>18</sup>F]BMS‐986192 PET/CT in patients with advanced stage non‐small‐cell lung cancer.